INNV: Inverse Head and Shoulders detected on 12 Nov 2026

All prices, scores, and news on this page reflect data available before market open on .

Free example: 1 of 47 setups from the 12 Nov 2026 scan. Subscribers get the full list every trading day by 6 AM ET.

On 12 Nov 2026, our scan flagged INNV as a inverse head and shoulders setup scoring 68 out of 98 (Moderate tier), with a 68% win probability based on our historical pattern database and a 0.33 to 1 risk to reward profile from the published levels. This is a swing trade setup: win probability reflects a multi-day swing hold, not an intraday move. At $9.50, the conservative target is $9.94 with a stop at $8.16.

68 of 98
Moderate
68%
Moderate
0.33 : 1
$0.44 to target $1.34 to stop
Swing Trading Plan
Entry
$9.50
$9.94
$8.16
2-8 trading days
Exp. Reward
+$0.23
Exp. Risk
-$0.21

Expected figures are probability-weighted from our historical pattern database; Trade R:R is measured from the entry, target and stop levels.

Current Setup
INNV is forming an inverse head-and-shoulders pattern at $9.50, sitting just 2% above the 9.94 conservative target. The pattern structure scores 9.0/15—modest but functional—while volume (12.0/12) and breakout scores (12.0/13) show conviction at resistance. At 68 overall quality, this is a medium-strength setup with 67.84% win probability. RSI at 53.69 is neutral, MACD positive at 0.0574, and volatility elevated at 55.16%. Price sits 24.84% below the 52-week high but 102% above the 52-week low, indicating recovery from deep lows. Support anchors at 8.79.
Stock Context
InnovAge reported Q4 FY2026 revenue of $261.95 million and net income of $8.29 million, shifting to profitability with $0.06 basic EPS. Full-year 2026 revenue reached $989.7 million, up 15.9% from $853.7 million in 2025, driven by capitation revenue from its PACE model. Operating income improved to $2.6 million in 2026 from a $29.8 million loss in 2025, with net loss narrowing to $2.5 million. Management guided FY2027 revenue of $1.05–$1.085 billion, signaling scale execution. The company reported leadership stability with Jennifer Browne appointed President and COO effective June 8, 2026. KeyBanc raised price target to $14 from $13 on September 9, 2026. However, a 10% owner sold shares in late September 2026 at $9.25 apiece, potentially weighing on momentum post-secondary offering.
What to Expect
A confirmed breakout above $9.94 (current resistance and conservative target) would complete the inverse head-and-shoulders and signal upside acceleration toward $10.50–$11.00 based on typical measured moves. Volume confirmation is needed—current relative volume at 0.64× versus 20-day average shows relative weakness, requiring volume ratio above 1.0× at breakout to validate breakout quality. The pattern invalidates decisively below 8.79 key support, where bulls would capitulate. The 67.84% win probability suggests this structure has solid statistical backing for continuation, though the moderate structure score of 9.0/15 indicates this is not a textbook formation.
Risk Factors
Three material risks emerge: First, insider selling pressure—a major shareholder sold shares at $9.25 in late September, near current levels, suggesting limited conviction from insiders at these prices. Second, volume drought: at 0.64× relative volume against 603,870-share 20-day average, conviction is muted; breakout may fail without institutional demand. Third, the healthcare sector is bullish (regime score 0.89) but broad market is bearish (-0.23), creating cross-current pressure. Low beta (0.39) provides downside protection but limits upside acceleration. Next earnings call is scheduled, and any guidance misses or PACE enrollment headwinds could trigger sharp reversal through support.
How We Find and Score This Setup
We scan more than 6,000 NYSE and NASDAQ stocks every trading day and compare each detected pattern against a database of 370,000+ historical detections. Every setup is scored across three dimensions: Structure, Volume, and Breakout Readiness. Win probability is a calibrated estimate of how similar historical setups performed over the following 10 trading days. This is a swing trading tool built for multi-day holds. It is not built or tested for day trading. What the terms mean →
Frequently Asked Questions
Is INNV a good swing trade?
INNV scored 68 out of 98 on our inverse head and shoulders scan, with a 68% historical win probability over a 2-8 trading days hold. Moderate setup based on our systematic scoring.
What is the entry, target, and stop loss for this setup?
The setup's reference price is $9.50, with a conservative target of $9.94 and a stop loss at $8.16.
What would invalidate this inverse head and shoulders setup?
A close below the stop loss at $8.16 would invalidate the setup and suggest the pattern has failed.
How is the win probability calculated?
Win probability is a calibrated estimate of how similar historical inverse head and shoulders setups performed over the following 10 trading days, drawn from a database of 370,000+ historical pattern detections across 6,000+ NYSE and NASDAQ stocks.
Market & Sector Regime
Market
Bearish -0.24
-1.0 0 +1.0
Health Care Sector
Bullish 0.89
-1.0 0 +1.0
Other Patterns Detected Today
Bull Flag
32 days in pattern
Moderate 27.8
Overall Score
33 of 40
Strong
Pattern Quality
14 of 20
Good
Setup
11 of 20
Fair
R/R
10 of 18
Fair
Context
Pattern Quality Score
9 of 15
Moderate
Structure
12 of 13
Exceptional
Breakout
12 of 12
Exceptional
Volume
Recent Performance
-3.0%
1W
+4.4%
2W
+5.3%
1M
-10.8%
3M
Momentum & Trend
RSI (14)
53.7
Neutral
MACD Histogram
+0.06
Bullish
Bollinger Band Position
80.7%
Upper Zone
Volatility & Risk
20-Day Volatility
0.55
Very High
ATR %
5.2%
High
Beta
0.39
Defensive
Volume Analysis
Volume Ratio
0.64x
Below Avg
20-Day Avg Vol
604K
shares / day
Current Volume
386K
shares traded
Price Levels
52W High
$12.64
Target
$9.94
Current
$9.50
Support
$8.79
Stop Loss
$8.16
Resistance
$6.21
52W Low
$4.70
Disclaimer: This analysis is algorithmically generated for educational purposes only and does not constitute financial advice. Past pattern performance does not guarantee future results. Win probabilities are based on historical data across 370,000+ observations. Always conduct your own research and consult a qualified financial advisor. AI-assisted contextual analysis by Claude (Anthropic). Indicators reflect values at time of detection.